Cargando…
Glagov revisited: coronary artery disease phenotype on non-invasive imaging provides rationale for implementing preventive pharmacotherapy—a case report
BACKGROUND: Glagov et al. showed that no reduction in vessel lumen occurred until the atherosclerotic plaque burden exceeded 40% of the vessel area. Most major adverse cardiac events occurring in the first 4 years after a myocardial infarction arise from untreated angiographically mild, non-flow-lim...
Autores principales: | Revaiah, Pruthvi C, Serruys, Patrick W, Yates, Denise P, Onuma, Yoshinobu, Luis Zamorano, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473852/ https://www.ncbi.nlm.nih.gov/pubmed/37662582 http://dx.doi.org/10.1093/ehjcr/ytad416 |
Ejemplares similares
-
Can machine learning unravel unsuspected, clinically important factors predictive of long-term mortality in complex coronary artery disease? A call for ‘big data’
por: Ninomiya, Kai, et al.
Publicado: (2023) -
Multi-Layer Mechanical Model of Glagov Remodeling in Coronary Arteries: Differences between In-Vivo and Ex-Vivo Measurements
por: Fok, Pak-Wing
Publicado: (2016) -
A reversal of Glagov's hypothesis; a preliminary demonstration by cardiac magnetic resonance
por: Kodali, Sobhan, et al.
Publicado: (2011) -
C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV
por: Nelson, Adam J., et al.
Publicado: (2020) -
The Rationale for Potential Pharmacotherapy of COVID-19
por: Saber-Ayad, Maha, et al.
Publicado: (2020)